Vistagen Therapeutics, Inc. VTGN
Set alert
0.17 USD 0.00 +1.91%
As of Nov 3, 11:22 AM ET
0.168 Day range 0.1748
0.168 52-week range 5.14
- YTD
- -74.14%
- 1 year
- -95.97%
- Open
- 0.169
- Prev close
- 0.1675
- Mkt cap
- 7.58M
- Vol
- 237.78K
- Avg vol
- 12.32M
- EPS
- -1.66
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.168
- High
- 0.1748
- Forward P/E
- -1.49
- Beta
- 0.00
- Short ratio
- 1.69
- Inst. own
- 53.63%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 2.81
- 200-d avg
- 3.60
- 1y target
- 13.00
5m chart
Built from the cached five-day intraday bars.
Signals (114)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 3, 9:55 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:45 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:45 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 9:40 AM | 1 hour ago |
| SMA: Bearish | Nov 3, 9:40 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bullish | Nov 3, 9:30 AM | 1 hour ago |
| SMA: Bearish | Nov 2, 3:55 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:55 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 19 hours ago |
| SMA: Bearish | Nov 2, 3:35 PM | 19 hours ago |
| SMA: Bullish | Nov 2, 3:15 PM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 3:15 PM | 20 hours ago |
| SMA: Bullish | Nov 2, 2:40 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 2:00 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:40 PM | 21 hours ago |
Newest 20 of 114.
Analyst view
Price target (mean) 13.00 +7515.7% upside
Now 0.1707
- Target (low)
- 12.00
- Target (mean)
- 13.00
- Target (high)
- 15.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.52 | -0.54 – -0.50 | -0.22 | -136.4% | 179.25K | -56.4% | 2 |
| Next quarter | -0.525 | -0.60 – -0.45 | -0.25 | -110.0% | 179.25K | -9.2% | 2 |
| Current year | -1.82 | -1.87 – -1.77 | -1.52 | -19.7% | 642.00K | -39.7% | 2 |
| Next year | -1.48 | -1.53 – -1.43 | -1.82 | +18.7% | 316.25K | -50.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 7, 2023 | Jefferies | Upgrade | Hold | Buy |
| Nov 14, 2023 | Stifel | Initiated | — | Buy |
| Sep 5, 2023 | Maxim Group | Maintained | Buy | Buy |
| Aug 7, 2023 | Maxim Group | Upgrade | Hold | Buy |